RESUMO
In the last 10 years, numbers of donors in the case of Polish potential unrelated hematopoietic stem cells (HSC) have increased dynamically, reaching 1,900,000 in 2020 (including donors presented in World Marrow Donor Association as PL6). On the world scale, the share of Polish donors in the global registry increased from 1% in 2010 to about 5% in 2020. The level and range of typing of potential donors has also been improving steadily toward the international "gold standard." At the end of 2020, 92% of Polish resources were at least HLA-A, B, C, DR, DQ high- or intermediate-resolution typed, mostly by way of genomic typing techniques, mostly by way of genomic typing techniques. The Central Bone Marrow Donor Registry (CBMDR) also stands out in terms of the young ages of potential donors. As of 2020, 27.2% of those registered were younger than 30 years of age, and 36.3% were aged between 30 and 40 years. Sixty percent of registered donors were female. The data in question were presented at the World Marrow Donor Association Search & Match Service, ensuring their visibility and accessibility to Polish and international search units and registries. In 2020, donors in Poland were the subject of almost 18,000 search requests from 40 countries, with 271 extended typing requests and more than 7600 confirmatory typing requests. The total number of donations from Polish donors also increased. In 2020, HSC of bone marrow, peripheral blood, or lymphocytes were collected from 1391 donors, as opposed to 94 donors in 2010. The growing number of donors available in the CBMDR means a better chance of a donor being found among Polish resources, without any need to resort to international registers. Although in 2010, just 24% of Polish recipients received HSC from Polish donors, by 2019 the figure was as high as 67%, and reached 63% in 2020. The CBMDR is an example of proper strategy on registry development being implemented in Poland.
Assuntos
Medula Óssea , Doenças Hematológicas , Adulto , Transplante de Medula Óssea , Feminino , Teste de Histocompatibilidade/métodos , Humanos , Masculino , Polônia , Sistema de Registros , Doadores de TecidosRESUMO
Chronic kidney disease (CKD) is a common complication of rheumatic disorders. We analyzed the incidence of different rheumatic conditions as a primary diagnosis of end-stage renal disease (ESRD) in kidney transplant recipients in Poland. Data were received from the national waiting list for organ transplantation (Poltransplant) registries. Primary diagnosis leading to ESRD were analyzed in 15,984 patients who received kidney transplants between 1998 and 2015. There was no information about primary diagnosis in 4981 cases (31%) and in 1482 cases (9%) the diagnosis was described as unknown. Rheumatic diseases were specified in 566 (5.14%) kidney transplant recipients: lupus erythematosus, (systemic lupus erythematous nephritis) in 211 (1.92%), vasculitis in 176 (1.60%), amyloidosis AA in 82 (0.75%), hemolytic uremic syndrome in 59 (0.54%), secondary glomerulonephritis in 24 (0.22%), scleroderma in 9 (0.08%), rheumatoid arthritis in 4 (0.04%) and Sjögren syndrome in 1 (0.01%). Graft survival at 1 and 5 years were significantly better in the nonrheumatic versus rheumatic group (90 vs 87% and 76 vs 72% respectively, P = .04). Recipient survival at 5 years was significantly better in the nonrheumatic versus the rheumatic group (88 vs 84%, P = .02). Our study showed that systemic lupus erythematosus and systemic vasculitides are the major rheumatic causes of ESRD in the Polish population. Long-term graft and recipient survival were significantly better in the nonrheumatic versus the rheumatic group in the Poltransplant cohort.
Assuntos
Falência Renal Crônica/etiologia , Transplante de Rim/estatística & dados numéricos , Doenças Reumáticas/epidemiologia , Transplantados , Listas de Espera , Adulto , Feminino , Glomerulonefrite/complicações , Sobrevivência de Enxerto , Síndrome Hemolítico-Urêmica/complicações , Humanos , Incidência , Falência Renal Crônica/cirurgia , Lúpus Eritematoso Sistêmico/complicações , Nefrite Lúpica/complicações , Masculino , Pessoa de Meia-Idade , Polônia/epidemiologia , Sistema de Registros , Doenças Reumáticas/complicações , Fatores de Risco , Resultado do TratamentoRESUMO
We aim to provide a panorama of liver donation and transplantation in Poland, where each year around 300 liver transplantations from deceased donors and 20 liver fragment transplantations from living donors are performed. This means about 9 transplantations per population of 1 million. Each year, the number of deceased donors reaches more than 500. In more than 50% of cases, livers are used. The law allows liver procurement from living donors. Until the end of 2013, liver fragments were recovered from 236 living donors and transplanted mainly to pediatric recipients (n = 232). A living-donor registry was created to monitor and assess the health condition of donors. The range of the national waiting list and allocation is nationwide. It is managed with the use of the Web tool www.rejestry.net. There are 2 modes of recipient referral: "urgent" and "elective." Allocation is either patient oriented and center oriented. Disease groups, which comprise the most frequent indications for transplantation in adults, include the cirrhosis group (48%), in which the highest number of procedures was performed for patients with hepatitis C virus (24%); alcohol-induced cirrhosis (14%); alcohol-induced hepatitis (8%), and hepatitis B virus cirrhosis (7%). Among pediatric recipients, the most frequent indications were congenital cholestatic diseases, which made up 38% of all transplantation indications. The results of liver transplantations are collected in the national transplant register. The 1-year graft and recipient survival with deceased donor transplantation are 81% and 84% and with living donor transplantation 86% and 89%. The 5-year graft and recipient survival in deceased donor transplantation are 69% and 73%, and in living donor transplantation are 80% and 83%.
Assuntos
Hepatopatias/cirurgia , Transplante de Fígado/estatística & dados numéricos , Doadores Vivos/estatística & dados numéricos , Sistema de Registros , Obtenção de Tecidos e Órgãos/estatística & dados numéricos , Listas de Espera , Adulto , Atresia Biliar/cirurgia , Carcinoma Hepatocelular/cirurgia , Criança , Colestase/congênito , Colestase/cirurgia , Feminino , Sobrevivência de Enxerto , Hepatite C Crônica/complicações , Hepatoblastoma/cirurgia , Degeneração Hepatolenticular/cirurgia , Humanos , Cirrose Hepática/etiologia , Cirrose Hepática/cirurgia , Cirrose Hepática Alcoólica/cirurgia , Neoplasias Hepáticas/cirurgia , Transplante de Fígado/tendências , Masculino , Polônia , Taxa de Sobrevida , Obtenção de Tecidos e Órgãos/tendênciasRESUMO
BACKGROUND: Poltransplant managed a national transplant registry with the use of the Web tool www.rejestry.net. It collects information about all organ transplantations in the country along with outcomes. This article presents a formal analysis of data collected in the registry for the years 1998 to 2014. MATERIALS AND METHODS: Results presented are actual, not extrapolated, numbers; these were calculated only for the events for which the observation was complete, meaning that a given term of follow-up had passed and the information on recipient's and graft survivals were available. RESULTS: All liver transplant procedures were registered from the years 1998 to 2014, with follow-up data completeness of 89% to 99%. Detailed statistical descriptions of liver transplant results were significantly better for transplants from living donors, in comparison to deceased donors, for pediatric recipients. Results for pediatric and adult recipients did not vary if the organ was from a deceased donor. Elective and primary transplantations have significantly better results in comparison to urgent and re-transplanted cases. Results depend on indications for transplantation. Significantly better results were obtained in the case of cholestatic diseases and cirrhosis other than hepatitis C virus. Significantly worse results were obtained in acute liver failure, independently of etiology. Results in the case of hepatitis C virus cirrhosis, metabolic diseases, and neoplasms do not vary significantly. CONCLUSIONS: The strength of these findings are based on the registry's reliability and completeness. The registry fulfills its aims related to collecting records and monitoring graft function, and recipient survival. The data are an important source of information, to be used by transplantation institutions and referred to in the literature.
Assuntos
Hepatopatias/cirurgia , Transplante de Fígado , Doadores Vivos , Sistema de Registros , Adulto , Criança , Colestase/cirurgia , Feminino , Sobrevivência de Enxerto , Hepatite C Crônica/complicações , Humanos , Cirrose Hepática/cirurgia , Falência Hepática Aguda/cirurgia , Neoplasias Hepáticas/cirurgia , Masculino , Polônia , Garantia da Qualidade dos Cuidados de Saúde , Qualidade da Assistência à Saúde , Reprodutibilidade dos Testes , Taxa de Sobrevida , Doadores de Tecidos , Obtenção de Tecidos e Órgãos , Resultado do TratamentoRESUMO
History of hematopoietic stem cell transplantations in Poland begins in early 1980s; the 1st bone marrow allotransplantation was performed in 1983 in the Central Clinical Hospital of the Military Medical Academy in Warsaw. Following years brought the 1st autologous stem cell transplantations. Ten years later, unrelated bone marrow transplantation was performed for the 1st time by the team of the Hematology and Blood and Marrow Transplantation Unit in Katowice. Since then, hematopoietic stem cell transplantation developed to be standard procedure and one of the most important therapies applied in leukemia treatment. The number of allotransplantations in Poland has grown significantly in the past 2 decades, which generated new needs and problems. In 2005, based on a new Transplant Law, a National Transplants Registry was created. Its main role is to collect data (registration of procedures and follow-up data) related to every transplantation case for stem cells and tissues as well as for organs. We present statistics concerning stem cell transplantations performed in Poland, as collected in the National Transplants Registry in the years 2006-2014. There are 18 centers transplanting hematopoietic stem cells in Poland. The total number of hematopoietic stem cell transplantations performed in 2006-2014 was 3,537, with allotransplantations from relatives accounted for 1,491 and from unrelated donors for 2,046. The main indication for allotransplantation in past years was acute leukemia.
Assuntos
Transplante de Células-Tronco Hematopoéticas/história , Transplante de Células-Tronco Hematopoéticas/métodos , Sistema de Registros , História do Século XX , História do Século XXI , Humanos , Internet , Leucemia/terapia , Polônia , Transplante HomólogoRESUMO
Possible adverse events and reactions associated with organ procurement and transplantation from deceased donors require compliance with quality and safety standards. Shortage of organs for transplantation makes it necessary to obtain organs from nonstandard (expanded-criteria) donors. This increases the risk of disease transmission with the graft which is difficult or impossible to identify before transplantation. The long-term access to biologic material of organ donors and recipients proffers the possibility to evaluate serious adverse reactions as well as to improve the quality and safety in transplantation medicine. Implementation of the above-mentioned tasks requires a Biobank whose aims are: to gather and long-term storage sera, lymph nodes, and other tissues of deceased organ donors for analysis of their biologic properties; to gather and store organ recipient sera; to determine methods to store biologic material in a manner enabling identification of the donor, organ, and recipients; and to provide electronic record keeping. Tactical tasks of a Biobank are: to carry out new or verify results of previously performed testing of deceased donors and recipients as controls to evaluate transmission of infection; to perform genetic material testing (NAT) to verify and confirm serologic tests, eg, determination of HIV RNA/DNA in donors at risk of infections; to discover rare diseases in donors and recipients whose detection before transplantation is difficult because of the time constraints related to organ storage or the lack of available methods (eg, sponge encephalopathies); to perform biochemical or genetic tests to evaluate neoplasia transfer from donor to recipient; and to reexamine HLA typing in cases of immunologic complications.
Assuntos
Bancos de Tecidos , Humanos , PolôniaRESUMO
BACKGROUND: Organ shortage is the primary barrier to kidney transplantation. To maximize organ use, organs from expanded-criteria donors (ECDs) have been used increasingly. Expanded-criteria donors are defined as individuals older than 60 years or older than 50 years with at least 2 of the following risk factors: hypertension, stroke as the cause of death, or serum creatinine concentration greater than 1.5 mg/dL. OBJECTIVE: To assess the incidence of complications posttransplantation in ECD kidneys compared with kidneys from standard-criteria cadaveric donors (SCDs). PATIENTS AND METHODS: One hundred seventy-two patients received cadaveric renal transplants between January 1, 2006, and August 31, 2008. Donor and recipient data were collected, as well as patient and graft survival and immediate, delayed, or slow graft function. Complication rates for lymphocele, urinary leak, thrombosis, hematoma, urinary tract infection, and cytomegalovirus infection were recorded. Follow-up was for 3 to 35 months, ending on November 30, 2008. RESULTS: Overall, mean 1-year graft survival was 86.9%, and mean creatinine concentration was 1.58 mg/dL. One incidence of primary nonfunction (0.6%) was observed. More than 25% of transplanted kidneys were from ECDs. No significant differences were noted in postoperative complications between recipients of ECD or SCD organs. CONCLUSION: The rate of complications in recipients of ECD and SCD kidneys is comparable.
Assuntos
Transplante de Rim/efeitos adversos , Seleção de Pacientes , Doadores de Tecidos/estatística & dados numéricos , Cadáver , Causas de Morte , Creatinina/sangue , Infecções por Citomegalovirus/epidemiologia , Seguimentos , Sobrevivência de Enxerto , Hematoma/epidemiologia , Humanos , Transplante de Rim/mortalidade , Transplante de Rim/fisiologia , Linfocele/epidemiologia , Pessoa de Meia-Idade , Complicações Pós-Operatórias/classificação , Complicações Pós-Operatórias/epidemiologia , Estudos Retrospectivos , Fatores de Risco , Fatores de Tempo , Infecções Urinárias/epidemiologiaRESUMO
OBJECTIVE: This study evaluated the frequency of microbial isolates and their susceptibility profiles among cultures from the "surgical site" of 26 simultaneous pancreas-kidney (SPKT) recipients in the early posttransplant period. PATIENTS AND METHODS: Data on microbiologic cultures of 26 adult patients undergoing SPKT were collected prospectively from 2001 to the end of 2006. The isolation and identification of cultured micro-organisms was performed according to standard microbiological procedures and commercially available tests. Susceptibility of the strains to antibacterial agents was made by the Clinical and Laboratory Standards Institute (CLSI) guidelines. RESULTS: All patients were followed prospectively for the first 4 weeks after surgery yielding 168 microbial isolates from the surgical site. The most commonly isolated organisms were Gram-positive bacteria (65.5%) with domination of staphylococci (52.7%) as methicillin-resistant S aureus and methicillin-resistant coagulase-negative staphylococci. The second most common were enterococci (33.6%) with the presence of an high level aminoglycoside-resistant strains (64.9%) and vancomycin-resistant strains (2.7%). Gram-negative bacteria comprised 19% of positive cultures; among them were isolated extended spectrum beta-lactamase producers and carbapenem-resistant strains. Yeast-like fungi comprised 15.5% of positive cultures. In conclusion, we observed predominantly Gram-positive bacteria, comprising 65.5% of isolates. The increased proportion of multi-drug-resistant bacterial isolates may be due to the frequent prophylaxis of bacterial infections in patients.
Assuntos
Transplante de Rim/efeitos adversos , Transplante de Pâncreas/efeitos adversos , Complicações Pós-Operatórias/microbiologia , Infecção da Ferida Cirúrgica/tratamento farmacológico , Adulto , Antibacterianos/administração & dosagem , Antibacterianos/uso terapêutico , Cadáver , Resistência a Múltiplos Medicamentos , Feminino , Infecções por Bactérias Gram-Positivas/tratamento farmacológico , Humanos , Imunossupressores/uso terapêutico , Infusões Intravenosas , Transplante de Rim/imunologia , Masculino , Staphylococcus aureus Resistente à Meticilina , Pessoa de Meia-Idade , Transplante de Pâncreas/imunologia , Complicações Pós-Operatórias/tratamento farmacológico , Complicações Pós-Operatórias/epidemiologia , Infecções Estafilocócicas/tratamento farmacológico , Infecção da Ferida Cirúrgica/epidemiologia , Doadores de TecidosRESUMO
OBJECTIVE: Urinary tract infection (UTI) is among the common infection in simultaneous pancreas-kidney transplantation (SPKT). PATIENTS AND METHODS: The study included 26 adult patients undergoing SPKT between September 2001 and December 2006. All the patients were followed prospectively for UTI during the first 4 weeks after surgery. Urine samples were investigated for bacteriologic cultures. The micro-organisms were identified in accordance with standard bacteriologic procedures. Susceptibility testing was carried out using Clinical and Laboratory Standards Institute (CLSI) procedures. RESULTS: Among 77 urine specimens obtained from all recipients during the first month, there were 30 isolated bacterial strains. The most common were Gram-positive bacteria (53.3%) with predominance of enterococci (75%) associated with high levels of aminoglycoside resistant strains (HLAR; 58.3%) and vancomycin-resistant strains (VRE; 25%). Gram-negative bacteria were detected in 46.7% of positive cultures. CONCLUSIONS: In our study, enterococci predominated as 75% of Gram-positive isolates. The increased proportion of multi-drug-resistant bacteria, which can caused severe UTI in patients after SPKT, may be due to the frequent use of prophylaxis of bacterial infections in patients.
Assuntos
Transplante de Rim/efeitos adversos , Transplante de Pâncreas/efeitos adversos , Infecções Urinárias/epidemiologia , Adulto , Antibacterianos/uso terapêutico , Antibioticoprofilaxia , Cadáver , Farmacorresistência Bacteriana , Feminino , Bactérias Gram-Positivas/isolamento & purificação , Humanos , Imunossupressores/uso terapêutico , Transplante de Rim/imunologia , Masculino , Testes de Sensibilidade Microbiana , Pessoa de Meia-Idade , Transplante de Pâncreas/imunologia , Doadores de TecidosRESUMO
BACKGROUND: Bacteremia is among the known complications in simultaneous pancreas-kidney transplantation (SPKT). This study evaluated the frequency of microbial isolates and their susceptibility profiles among cultures of clinical samples obtained from blood and from the tips of blood vessel catheters of 26 SPKT recipients suspected of bacteremia in the early posttransplant period. PATIENTS AND METHODS: Data on microbiologic blood cultures of 26 adult patients undergoing SPKT were collected prospectively from 2001 to the end of 2006. The isolation and identification of cultured microorganisms were performed according to standard microbiological procedures and commercially available tests. The susceptibility of the strains to antibacterial agents was established by the Clinical and Laboratory Standards Institute guidelines. RESULTS: All patients were followed prospectively for the first 4 weeks after surgery. Among 66 clinical samples, there were 23 microbial isolates from blood samples of 17 recipients and catheter tips of 12 recipients. The most common isolates were Gram-positive bacteria (73.9%) with domination of staphylococci (64.7%) and MRCNS strains (81.8%). Gram-negative bacteria comprised 17.4% of positive cultures, whereas yeast-like fungi, 8.7% with a predominance of Candida glabrata. CONCLUSION: Our study showed predominately Gram-positive bacteria in 73.9% of isolates. The increased proportion of multi-drug-resistant bacteria and fungi to antimicrobial agents may be due to the frequent use of these agents for prophylaxis of bacterial infections in patients.
Assuntos
Antibacterianos/uso terapêutico , Bacteriemia/epidemiologia , Transplante de Rim/efeitos adversos , Transplante de Pâncreas/efeitos adversos , Adulto , Antibacterianos/farmacologia , Bacteriemia/tratamento farmacológico , Bacteriemia/etiologia , Feminino , Bactérias Gram-Positivas/isolamento & purificação , Humanos , Imunossupressores/uso terapêutico , Masculino , Staphylococcus aureus Resistente à Meticilina , Pessoa de Meia-Idade , Ácido Micofenólico/uso terapêutico , Período Pós-Operatório , Estudos Retrospectivos , Staphylococcus/efeitos dos fármacosRESUMO
Simultaneous pancreas-kidney transplantation (SPKT) improves long-term survival of insulin-dependent diabetes mellitus patients with diabetic nephropathy. The increasing success of SPKT is a result of improved surgical technique, better organ preservation, potent antirejection therapy, and effective use of antibiotics to prevent and treat infectious complications. However, morbidity and mortality following SPKT remain high mainly owing to infection. From 1988 to 2004, the 51 patients who underwent SPKT were 32 women and 19 men of mean age 34 +/- 4 years old with diabetes and end-stage renal disease. The mean duration of diabetes mellitus was 23 +/- 4 years. The incidence of HCV and HBV infections were 19.6% and 13.7%, respectively. Preoperative work-up included identification and elimination prior to surgery of potential sources of infection. All patients prior to SPKTx had been treated by dialysis (26 +/- 20 months). The kidneys were always placed into the left retroperitoneal space first; at the same time the pancreatic grafts were prepared on the back table. The reconstruction of the superior mesenteric and the splenic arteries was performed using a Y graft of donor iliac artery to the common or external donor's iliac artery. The pancreas was transplanted intraperitoneally to the right iliac vessels. The portal vein was sutured to the common or external iliac vein and the arterial conduit of donor iliac artery. In 20 of the patients, bladder drainage and in 31, enteric drainage was used for the pancreatic juice exterioration. Patients received immunosuppression with a calcineurin inhibitor (tacrolimus or cyclosporin), mycophenolic acid or azathioprine, and steroids. Antibody induction (alternatively anti-IL-2 monoclonal antibody or ATG) was used in last 38 patients. Antibacterial (tazobactam) and antifungal (fluconazole) as well as antiviral (gancyclovir) prophylactic treatment was given to all patients for 7 to 10 days after transplantation. Thirty-eight recipients are alive, 26 with function of both grafts; 8 with functioning kidney grafts; and 4 with nonfunctioning grafts on dialysis treatment from 1 to 14 years after transplantation. Thirteen patients (24.5%) died during the first year after transplantation. Infectious complications were the main cause of death. Systemic infections accounted for the death of five patients and CNS infection for death of another five patients. Three patients died with functioning grafts due to cardiopulmonary disorders (myocardial infarction, pulmonary embolus) early in the postoperative period. A total of 102 infections were diagnosed in 51 patients during the posttransplant course. Twenty-one episodes of CMV infection (systemic 20, duodenal site 1), 73 bacterial infections (systemic 13, pulmonary 13, urinary tract 15, intestinal 8, wound 23), and 8 fungal infections (central nervous system 5, gastrointestinal tract 3). Some patients had more than one type of infection. Overall mortality in the investigated group was 24.5%. Infectious complications were the main cause of death (77%), including systemic infection (38.5%) and CNS infection (38.5%). The predominant etiology of the systemic infections was bacterial. The etiology of CNS infections was fungal. In conclusion, infectious complications are the main cause of morbidity and mortality following SPKT. The early diagnosis of infection, particularly fungal complications, is necessary. The administration of broad-spectrum prophylactic antibiotics, antifungal, and antiviral agents is recommended.
Assuntos
Transplante de Rim/efeitos adversos , Transplante de Pâncreas/efeitos adversos , Infecção da Ferida Cirúrgica/epidemiologia , Adulto , Anticorpos Monoclonais/uso terapêutico , Bacteriemia/epidemiologia , Infecções Bacterianas/epidemiologia , Infecções por Citomegalovirus/epidemiologia , Feminino , Humanos , Terapia de Imunossupressão/métodos , Transplante de Rim/imunologia , Transplante de Rim/mortalidade , Masculino , Micoses/epidemiologia , Transplante de Pâncreas/imunologia , Transplante de Pâncreas/mortalidade , Infecções Respiratórias/epidemiologia , Estudos RetrospectivosAssuntos
Diabetes Mellitus Tipo 1/cirurgia , Sobrevivência de Enxerto/fisiologia , Transplante de Rim , Transplante de Pâncreas , Complicações Pós-Operatórias/classificação , Adulto , Diabetes Mellitus Tipo 1/tratamento farmacológico , Nefropatias Diabéticas/cirurgia , Feminino , Humanos , Insulina/uso terapêutico , Masculino , Complicações Pós-Operatórias/epidemiologia , Terapia de Substituição Renal , Reoperação/estatística & dados numéricos , Estudos Retrospectivos , Fatores de Tempo , Falha de Tratamento , Resultado do TratamentoRESUMO
Pesticides as environmental pollutants are described in detail along with their sources and paths of entry into various elements of the environment. Comprehensive literature data on the concentration of these pollutants in natural and treated waters and wastewaters are discussed. A wide selection of isolation and preconcentration techniques for these pollutants in water is presented and discussed. An emphasis is put on solid-phase extraction. In the case of the authors' work, a more detailed description is given.
Assuntos
Resíduos de Praguicidas/análise , Poluentes Químicos da Água/análise , Humanos , Resíduos de Praguicidas/isolamento & purificação , Poluentes Químicos da Água/isolamento & purificaçãoRESUMO
The recovery of pancreatic islet cells from cadaveric donors for allotransplantation may depend on the functional condition of the pancreas of the donor prior to organ harvesting. We examined donor hemodynamic and biochemical parameters and their effects on the subsequent yield of islet cells after harvesting. All pancreata were flushed and preserved in University of Wisconsin (UW) solution and digested using automated method within 8 hours. In the first analysis, digestions were divided into high-yield (> 2000 IEQ/g pancreas), and low-yield (< 2000 IEQ/g) groups and donor variables were averaged for each group. Donors whose pancreata yielded > 2000 IEQ/g received significantly greater amounts of Dopamine (14.43 micrograms/kg/min vs 9.35 mg/kg/min, p = 0.05). The daily urine output between groups was also significantly different. Maximum systolic blood pressure (SBP), minimum systolic blood pressure, use of vasopressin, length of hospitalization, and maximum base deficit were compared between the two groups. Less severe hypoglycemia (lowest blood glucose 143 mg/dL vs 107 mg/dL, p = 0.02) and lower amylase levels (36.2 U vs 80.7, p = 0.07 were noted in the high-yield group. A trend towards higher islet yields was associated with lowest hourly urine output > 60 (2040 IEQ/g vs 1649 IEQ/g p = 0.09), maximum SBP > 200 (2097 vs 1673, p = 0.07, and surprisingly, lowest SBP below 80 (2013 vs 1742, p < 0.1). Amount of fluids administered prior to procurement had no influence on islet yield. In conclusion, hemodynamic variables such as urine output, systolic blood pressure, and degree of pressor support were modestly associated with successful islet isolation. The preliminary data suggest that better multifactor donor analysis is imperative for standardization and monitoring of multiorgan donors. The association of higher blood glucose levels with successful isolation may also be related to resuscitation with dextrose-containing fluids.